Neurofibromatosis associated with malignant neurofibromas.
D000230:Adenocarcinoma / Q000150:complications; D000310:Adrenal Gland Neoplasms / Q000150:complications; D000328:Adult; D000368:Aged; D002280:Basal Cell Carcinoma / Q000150:complications* / Q000473:pathology; D002294:Carcinoma, Squamous Cell / Q000150:complications; D002648:Child; D005260:Female; D005354:Fibrosarcoma / Q000150:complications; D006801:Humans; D008297:Male; D008545:Melanoma / Q000150:complications* / Q000473:pathology; D008875:Middle Aged; D009062:Mouth Neoplasms / Q000150:complications; D009378:Neoplasms, Multiple Primary; D009455:Neurofibroma / Q000150:complications* / Q000473:pathology; D009456:Neurofibromatosis 1 / Q000150:complications*; D009669:Nose Neoplasms / Q000150:complications; D010157:Palatal Neoplasms / Q000150:complications; D010190:Pancreatic Neoplasms / Q000150:complications; D010673:Pheochromocytoma / Q000150:complications; D012878:Skin Neoplasms / Q000473:pathology